Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that ...

Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had been ...

Real-world data demonstrate that the MiniMed 780G system effectively controls glucose levels in users who do not administer ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with type 2 diabetes lowered their HbA1c from ...

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...

People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain healthy levels of the hormone, as their bodies do not naturally produce enough. The ...

In a recent study published in Nature, researchers report the design and experimental efficacies of NNC2215, a novel insulin conjugate comprising synthetically added glucose-binding macrocycles and ...

The Omnipod 5 will be immediately available for people ages 6 to 70. A new technology for people with Type 1 diabetes, one that has been nearly a decade in the making, has been approved by the U.S.

For people managing prediabetes or diabetes, movement can be one of the fastest natural ways to bring down high blood sugar ...

Insulin resistance has been found in adolescents with PCOS, however, health care providers are not always testing and monitoring for this early in a female’s life. This is the third installment of a 6 ...